METASTATIC COLON CANCER
Clinical trials for METASTATIC COLON CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLON CANCER trials appear
Sign up with your email to follow new studies for METASTATIC COLON CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test could personalize chemo breaks for advanced colon cancer
Disease control Not yet recruitingThis phase 3 trial tests whether a blood test that measures tumor DNA (ctDNA) can help doctors decide when to reduce or switch chemotherapy in people with metastatic colorectal cancer. About 408 participants will be randomly assigned to either standard treatment or a strategy whe…
Matched conditions: METASTATIC COLON CANCER
Phase: PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New drug cocktail targets cancers missing key gene
Disease control Not yet recruitingThis study tests a new drug combination for people with metastatic solid tumors that lack a gene called MTAP. The drugs, BMS-986504 and pemetrexed, aim to stop cancer cells from growing. The trial will check safety and how well the combo works in 72 participants.
Matched conditions: METASTATIC COLON CANCER
Phase: PHASE1, PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
AI-Powered test aims to predict best cancer treatment for each patient
Diagnosis Not yet recruitingThis study tests a new platform called xDRIVE that combines drug sensitivity testing and AI to predict which treatments will work best for people with advanced colorectal cancer. The platform will not provide treatment itself but will give doctors a recommendation. The goal is to…
Matched conditions: METASTATIC COLON CANCER
Sponsor: First Ascent Biomedical Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 17:44 UTC